Literature DB >> 25373848

Synthesis and biological activity of substituted-4,5,6,7-tetrahydrothieno pyridines: a review.

Jaiprakash N Sangshetti, Abhay S Zambare, Firoz A Kalam Khan, Indrajeet Gonjari, Zahid Zaheer1.   

Abstract

4,5,6,7-Tetrahydrothieno pyridine is an important class of heterocyclic nucleus. Various 4,5,6,7-tetrahydrothieno pyridine derivatives have been synthesized and evaluated for various biological activities in different models with desired findings. Some analogs have shown potent biological activities and may be considered as lead molecule for the development of future drugs. Number of drug molecules are available in the market and many molecules are in clinical development containing 4,5,6,7-tetrahydrothieno pyridine nucleus as an important core. This review is an attempt to organize the chemical and biological aspects of 4,5,6,7-tetrahydrothieno pyridine analogs reported in last 20 year to till date. Review mainly focuses on the important role of the core in synthesis of drug or drug intermediates giving emphasis on synthetic schemes and biological activities of the different 4,5,6,7-tetrahydrothieno pyridine analogs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373848     DOI: 10.2174/1389557514666141106131425

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  Identification of Novel Protein Kinase Receptor Type 2 Inhibitors Using Pharmacophore and Structure-Based Virtual Screening.

Authors:  Josiane V Cruz; Moysés F A Neto; Luciane B Silva; Ryan da S Ramos; Josivan da S Costa; Davi S B Brasil; Cleison C Lobato; Glauber V da Costa; José Adolfo H M Bittencourt; Carlos H T P da Silva; Franco H A Leite; Cleydson B R Santos
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

2.  Antiproliferative Activity of Some Newly Synthesized Substituted Nicotinamides Candidates Using Pyridine-2(1H) thione Derivatives as Synthon.

Authors:  Dina H Elnaggar; Ashraf M Mohamed; Naglaa A Abdel Hafez; Mohamed E Azab; Manar E A Elasasy; Hanem M Awad; Thoraya A Farghaly; Abd El-Galil E Amr
Journal:  ACS Omega       Date:  2022-03-16

3.  Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein.

Authors:  Raphaël De Matos; Jérémy Vuilleumier; Christophe Mas; Samuel Constant; Davide Staedler; Sandrine Gerber-Lemaire
Journal:  RSC Adv       Date:  2019-10-04       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.